Fengzhen Mo
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
Papers in
- Immunology 10
- Immunotherapy and Immune Responses 10
- Oncology 10
- Cancer Immunotherapy and Biomarkers 6
- CAR-T cell therapy research 5
- Co-authors
- Xiaoling Lü (22 shared papers)Xiaoqiong Hou (15 shared papers)Zhuoran Tang (10 shared papers)Xiaomei Yang (17 shared papers)Aiqun Liu (14 shared papers)Siliang Duan (8 shared papers)Shihua Yin (8 shared papers)Zixi Hu (6 shared papers)
- Journals
- Journal of Biomedical Nanotechnology (5 papers)Theranostics (4 papers)International Journal of Nanomedicine (3 papers)Journal of Hematology & Oncology (2 papers)Journal of Nanoscience and Nanotechnology (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Fengzhen Mo
22 papers receiving 538 citations
Peers
Comparison fields: 5 of 50
- Immunology 157
- Oncology 166
- Biomaterials 82
- Radiology, Nuclear Medicine and Imaging 105
- Drug Discovery 1
Countries citing papers authored by Fengzhen Mo
This map shows the geographic impact of Fengzhen Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengzhen Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengzhen Mo more than expected).
Fields of papers citing papers by Fengzhen Mo
This network shows the impact of papers produced by Fengzhen Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengzhen Mo. The network helps show where Fengzhen Mo may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengzhen Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 85 | |
| 2 | 2021 | 64 | |
| 3 | 2018 | 40 | |
| 4 | 2020 | 39 | |
| 5 | 2021 | 36 | |
| 6 | 2017 | 33 | |
| 7 | 2018 | 31 | |
| 8 | 2019 | 31 | |
| 9 | 2019 | 23 | |
| 10 | 2023 | 22 | |
| 11 | 2019 | 18 | |
| 12 | 2023 | 18 | |
| 13 | 2024 | 18 | |
| 14 | 2019 | 17 | |
| 15 | 2018 | 16 | |
| 16 | 2019 | 15 | |
| 17 | 2020 | 13 | |
| 18 | 2021 | 13 | |
| 19 | 2019 | 7 | |
| 20 | 2025 | 5 |
About Fengzhen Mo
Fengzhen Mo is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Biomaterials and Molecular Biology, having authored 23 papers that have together received 547 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Nanoparticle-Based Drug Delivery (2 papers), RNA Interference and Gene Delivery (1 paper), Advanced biosensing and bioanalysis techniques (1 paper) and Wnt/β-catenin signaling in development and cancer (1 paper). The work is most often cited by research in Immunology (157 citations), Oncology (166 citations), Biomaterials (82 citations), Radiology, Nuclear Medicine and Imaging (105 citations) and Drug Discovery (1 citation). Fengzhen Mo has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiaoling Lü, Xiaoqiong Hou, Zhuoran Tang, Xiaomei Yang, Aiqun Liu, Siliang Duan, Shihua Yin, Zixi Hu, Xiaomei Yang and Shenxia Xie. Their work appears in journals such as Journal of Biomedical Nanotechnology, Theranostics, International Journal of Nanomedicine, Journal of Hematology & Oncology and Journal of Nanoscience and Nanotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.